Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 2 Thiol L Histidine Betaine
2. 2-thiol-l-histidine-betaine
3. Thioneine
1. L-(+)-ergothioneine
2. 497-30-3
3. L-ergothioneine
4. Sympectothion
5. Ergothionine
6. L-thioneine
7. Thiolhistidine-betaine
8. Thioneine
9. (s)-3-(2-thioxo-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylammonio)propanoate
10. Bdz3dqm98w
11. 58511-63-0
12. L(+)-ergothioneine
13. Thiasine
14. (2s)-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-(trimethylazaniumyl)propanoate
15. (s)-(1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl)trimethylammonium Hydroxide
16. Unii-bdz3dqm98w
17. Erythrothioneine
18. L-ergothionine
19. Ergothioneine Thiol
20. Ergothioneine Thione
21. Nsc 7175
22. Thiolhistidinebetaine
23. Einecs 207-843-5
24. Mfcd00167474
25. Ergothioneine L-(+)
26. Ergothioneine Thione Form
27. Ai3-23492
28. Ergothioneine [mi]
29. Ergothioneine (thione Form)
30. Ergothioneine [inci]
31. Schembl188140
32. Chebi:4828
33. Schembl9985141
34. Chebi:82707
35. Dtxsid901020082
36. Hms2089d04
37. 2-mercaptohistidine Trimethylbetaine
38. Hy-n1914
39. Ccg-207908
40. 1h-imidazole-4-ethanaminium, .alpha.-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (.alpha.s)-
41. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (s)-
42. Cs-0018211
43. D83035
44. Ab01275464-01
45. A930109
46. Ergothionine;l-(+)-ergothioneine;erythrothioneine
47. Q614788
48. (2s)-3-(2-mercapto-1h-imidazol-5-yl)-2-(trimethylammonio)propanoate
49. (2s)-3-(2-mercapto-1h-imidazol-5-yl)-2-(trimethylazaniumyl)propanoate
50. 3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)-2-trimethylammonio-propanoate
51. Nalpha,nalpha,nalpha-trimethyl-2-sulfanylidene-2,3-dihydro-l-histidine
52. (2s)-3-(2-sulfanylidene-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate
53. (2s)-3-(2-thioxo-2,3-dihydro-1h-imidazol-4-yl)-2-(trimethylazaniumyl)propanoate
54. (.alpha.s)-.alpha.-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-1h-imidazole-4-ethanaminium Inner Salt
55. (alphas)-alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-1h-imidazole-4-ethanaminium Inner Salt
56. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Hydroxide, Inner Salt, (s)-
57. 1h-imidazole-4-ethanaminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Inner Salt, (alphas)-
58. 1h-imidazole-4-ethaniminium, Alpha-carboxy-2,3-dihydro-n,n,n-trimethyl-2-thioxo-, Hydroxide, Inner Salt, (s)-
59. Ammonium, (1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl)trimethyl-, Hydroxide, Inner Salt, L-(+)-
| Molecular Weight | 229.30 g/mol |
|---|---|
| Molecular Formula | C9H15N3O2S |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 96.3 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 314 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.




FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Comhony Biotech manufactures fermentation & semi-synthetic APIs which aim at dermatology, anti-biotics; mitochondria & memory health.
About the Company : Comhony Biotech supplies APIs and nutraceutical ingredients to pharmaceutical and nutraceutical clients worldwide. Using proprietary technologies, the company manufactures fermenta...
About the Company : Anthem Biosciences is a leading contract research and innovation service provider (CRISP) in Bengaluru, India, which manufactures novel drug actives. Established in 2007, it specia...

About the Company : KansenBio is a pioneering biotechnology company founded in 2022 as a spin-off from Tsinghua University, dedicated to creating a healthier, greener future through nature-inspired bi...

About the Company : Benepure is a global research, manufacture and supplier of ingredients and their derivatives for healthcare industry. It owns strong research and development team, cutting-edge equ...

About the Company : Suzhou Ryway Biotech Co., Ltd. is located in Suzhou of Jiangsu Provice. It is a comprehensive enterprise integrated of product research, manufacturing, marketing and service. There...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Details:
Whey Protein is a protein drug, which is currently being evaluated in clinical studies for the treatment of aging.
Lead Product(s): Whey Protein,Creatine Monohydrate,Fucoidan,Urolithin A,Nicotinamide Mononucleotide,Multivitamin,L-Ergothioneine
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Protein
Sponsor: Xprize Foundation | Abinopharm Inc | DoNotAge.org
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 05, 2026

Lead Product(s) : Whey Protein,Creatine Monohydrate,Fucoidan,Urolithin A,Nicotinamide Mononucleotide,Multivitamin,L-Ergothioneine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Xprize Foundation | Abinopharm Inc | DoNotAge.org
Deal Size : Inapplicable
Deal Type : Inapplicable
PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)
Details : Whey Protein is a protein drug, which is currently being evaluated in clinical studies for the treatment of aging.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 05, 2026

Details:
Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): L-Ergothioneine,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Amino Acid
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 20, 2025

Lead Product(s) : L-Ergothioneine,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition
Details : Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
March 20, 2025

Details:
Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): L-Ergothioneine,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Amino Acid
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 13, 2021

Lead Product(s) : L-Ergothioneine,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study on Rapid Antioxidant Protection and Immune Modulating Effects.
Details : Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
September 13, 2021

Details:
L-Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): L-Ergothioneine,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Amino Acid
Sponsor: Blue California Company
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 21, 2020

Lead Product(s) : L-Ergothioneine,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Blue California Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
Details : L-Ergothioneine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
September 21, 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
52
PharmaCompass offers a list of L-Ergothioneine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Ergothioneine manufacturer or L-Ergothioneine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Ergothioneine manufacturer or L-Ergothioneine supplier.
PharmaCompass also assists you with knowing the L-Ergothioneine API Price utilized in the formulation of products. L-Ergothioneine API Price is not always fixed or binding as the L-Ergothioneine Price is obtained through a variety of data sources. The L-Ergothioneine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Ergothioneine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Ergothioneine, including repackagers and relabelers. The FDA regulates L-Ergothioneine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Ergothioneine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Ergothioneine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Ergothioneine supplier is an individual or a company that provides L-Ergothioneine active pharmaceutical ingredient (API) or L-Ergothioneine finished formulations upon request. The L-Ergothioneine suppliers may include L-Ergothioneine API manufacturers, exporters, distributors and traders.
click here to find a list of L-Ergothioneine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Ergothioneine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Ergothioneine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Ergothioneine GMP manufacturer or L-Ergothioneine GMP API supplier for your needs.
A L-Ergothioneine CoA (Certificate of Analysis) is a formal document that attests to L-Ergothioneine's compliance with L-Ergothioneine specifications and serves as a tool for batch-level quality control.
L-Ergothioneine CoA mostly includes findings from lab analyses of a specific batch. For each L-Ergothioneine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Ergothioneine may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Ergothioneine EP), L-Ergothioneine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Ergothioneine USP).